Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea
· Delayed Price · Currency is KRW
156,000
-1,900 (-1.20%)
At close: Jun 17, 2025, 3:30 PM KST
Daewoong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 17, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,794,978 | 1,454,393 | 1,343,932 | 1,754,469 | 1,638,243 | 1,775,845 | |
Market Cap Growth | -6.84% | 8.22% | -23.40% | 7.09% | -7.75% | 25.14% | |
Enterprise Value | 2,518,581 | 2,099,040 | 1,735,899 | 2,148,696 | 2,022,062 | 2,205,804 | |
Last Close Price | 156000.00 | 126400.00 | 116232.55 | 156907.02 | 145950.84 | 162053.57 | |
PE Ratio | 46.64 | 58.80 | 11.04 | 41.54 | 66.85 | 139.25 | |
Forward PE | 14.71 | 14.39 | 14.77 | 22.77 | 41.35 | 41.35 | |
PS Ratio | 1.24 | 1.02 | 0.98 | 1.37 | 1.42 | 1.68 | |
PB Ratio | 1.93 | 1.57 | 1.47 | 2.37 | 2.35 | 2.55 | |
P/TBV Ratio | 3.99 | 2.24 | 2.15 | 3.79 | 3.83 | 4.26 | |
P/FCF Ratio | - | - | 50.39 | 33.11 | 150.21 | 23.84 | |
P/OCF Ratio | 46.58 | 28.25 | 9.88 | 14.84 | 40.96 | 17.59 | |
PEG Ratio | 0.27 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | |
EV/Sales Ratio | 1.74 | 1.48 | 1.26 | 1.68 | 1.75 | 2.09 | |
EV/EBITDA Ratio | 13.88 | 10.81 | 10.53 | 15.86 | 15.60 | 38.12 | |
EV/EBIT Ratio | 19.09 | 14.45 | 14.33 | 22.43 | 22.79 | 129.91 | |
EV/FCF Ratio | -25.32 | - | 65.09 | 40.55 | 185.40 | 29.61 | |
Debt / Equity Ratio | 0.75 | 0.74 | 0.52 | 0.60 | 0.64 | 0.64 | |
Debt / EBITDA Ratio | 3.44 | 3.52 | 2.85 | 3.30 | 3.44 | 7.70 | |
Debt / FCF Ratio | - | - | 17.61 | 8.43 | 40.87 | 5.98 | |
Asset Turnover | 0.76 | 0.76 | 0.83 | 0.86 | 0.83 | 0.81 | |
Inventory Turnover | 2.67 | 2.77 | 3.06 | 3.39 | 3.54 | 3.47 | |
Quick Ratio | 0.54 | 0.52 | 0.45 | 0.68 | 0.72 | 0.99 | |
Current Ratio | 1.05 | 0.97 | 0.83 | 1.16 | 1.13 | 1.62 | |
Return on Equity (ROE) | 3.78% | 2.54% | 14.52% | 5.44% | 4.32% | 3.63% | |
Return on Assets (ROA) | 5.08% | 4.84% | 4.54% | 4.03% | 3.99% | 0.81% | |
Return on Capital (ROIC) | 6.35% | 6.07% | 5.89% | 5.14% | 4.86% | 0.98% | |
Return on Capital Employed (ROCE) | 11.00% | 10.80% | 11.30% | 8.80% | 9.30% | 1.60% | |
Earnings Yield | 2.14% | 1.70% | 9.06% | 2.41% | 1.50% | 0.72% | |
FCF Yield | -5.54% | -7.13% | 1.98% | 3.02% | 0.67% | 4.20% | |
Dividend Yield | 0.38% | 0.47% | - | - | - | - | |
Payout Ratio | 20.11% | 31.30% | 5.98% | 19.10% | 26.35% | 48.56% | |
Buyback Yield / Dilution | -0.00% | -0.71% | -3.21% | -0.59% | -3.21% | -3.31% | |
Total Shareholder Return | 0.38% | -0.24% | -3.21% | -0.59% | -3.21% | -3.31% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.